Why Trump reversed course to fast-track psychedelic drugs for mental healthcare
RSS SUMMARY · AGGREGATED FROM CNBC
President Donald Trump is trying to fast-track research into psychedelics as treatments, creating new opportunities and risks.
President Donald Trump is trying to fast-track research into psychedelics as treatments, creating new opportunities and risks.
President Donald Trump is trying to fast-track research into psychedelics as treatments, creating new opportunities and risks.
Continue Reading
The full story continues on CNBC.
Story Sentry shows a short summary aggregated via RSS. The complete article — original photography, charts, and reporting — lives with the publisher.
The Source
CNBC
Business
A hotly debated lung cancer drug cut the risk of death by 34% in a late-stage trial in China
CNBC·2h ago·3 min read
Business
Disney is poised to ramp its already booming advertising business. Rita Ferro is behind the push
CNBC·4h ago·3 min read
US
DOJ seeks Judge Eleanor Ross recusal in Georgia election case, citing reports she was disciplined
CNBC·21h ago·3 min read
US
Meta has struggled at selling anything other than ads. Will AI be different?
CNBC·1d ago·3 min read
Related
On this beat
Business
Secretary Bessent has firm take on Fort Knox gold debate
THE STREET·53m ago·3 min read
Business
Dave Ramsey, IRS sound alarm on major 401(k) problem
THE STREET·1h ago·3 min read
Business
BofA resets MongoDB stock price target after earnings
THE STREET·1h ago·3 min read
Business
I have 3 sons, so I’m the only woman in the house. I decluttered my attic to turn it into my peaceful, feminine sanctuary.
BI·1h ago·3 min read